IFN-β has pleiotropic effects on the peripheral immune system including the reduction of pathogenic Th1 and Th17 cells and an increase in IL-10-producing Treg cells, which are thought to be beneficial for MS [11]. The gene discussed is IFNB1; the disease is myeloid sarcoma.